|
1
|
Linearized reference tissue parametric imaging methods: application to [11C]DASB positron emission tomography studies of the serotonin transporter in human brain.
|
J Cereb Blood Flow Metab
|
2003
|
3.77
|
|
2
|
Inhibitory effect of hippocampal 5-HT1A receptors on human explicit memory.
|
Am J Psychiatry
|
2003
|
1.53
|
|
3
|
Regional dopamine synthesis in patients with schizophrenia using L-[beta-11C]DOPA PET.
|
Schizophr Res
|
2008
|
1.53
|
|
4
|
The effect of scatter correction on 123I-IMP brain perfusion SPET with the triple energy window method in normal subjects using SPM analysis.
|
Eur J Nucl Med Mol Imaging
|
2002
|
1.45
|
|
5
|
No association between genotype of the promoter region of serotonin transporter gene and serotonin transporter binding in human brain measured by PET.
|
Synapse
|
2003
|
1.44
|
|
6
|
Quantitative analyses of 18F-FEDAA1106 binding to peripheral benzodiazepine receptors in living human brain.
|
J Nucl Med
|
2006
|
1.36
|
|
7
|
Template-based method for multiple volumes of interest of human brain PET images.
|
Neuroimage
|
2002
|
1.23
|
|
8
|
Novel peripheral benzodiazepine receptor ligand [11C]DAA1106 for PET: an imaging tool for glial cells in the brain.
|
Synapse
|
2004
|
1.20
|
|
9
|
Quantitative analysis for estimating binding potential of the peripheral benzodiazepine receptor with [(11)C]DAA1106.
|
J Cereb Blood Flow Metab
|
2006
|
1.20
|
|
10
|
Quantitative analysis of 11C-verapamil transfer at the human blood-brain barrier for evaluation of P-glycoprotein function.
|
J Nucl Med
|
2006
|
1.12
|
|
11
|
Serotonin transporter binding in patients with mood disorders: a PET study with [11C](+)McN5652.
|
Biol Psychiatry
|
2002
|
1.09
|
|
12
|
Effects of dopaminergic and serotonergic manipulation on emotional processing: a pharmacological fMRI study.
|
Neuroimage
|
2005
|
1.07
|
|
13
|
High levels of serotonin transporter occupancy with low-dose clomipramine in comparative occupancy study with fluvoxamine using positron emission tomography.
|
Arch Gen Psychiatry
|
2003
|
1.01
|
|
14
|
Functional neuroimaging in multiple sclerosis with radiolabelled glia markers: preliminary comparative PET studies with [11C]vinpocetine and [11C]PK11195 in patients.
|
J Neurol Sci
|
2007
|
0.99
|
|
15
|
Memory and frontal lobe functions; possible relations with dopamine D2 receptors in the hippocampus.
|
Neuroimage
|
2006
|
0.96
|
|
16
|
Dose-finding study of paliperidone ER based on striatal and extrastriatal dopamine D2 receptor occupancy in patients with schizophrenia.
|
Psychopharmacology (Berl)
|
2007
|
0.95
|
|
17
|
[11C]AZ10419369: a selective 5-HT1B receptor radioligand suitable for positron emission tomography (PET). Characterization in the primate brain.
|
Neuroimage
|
2008
|
0.93
|
|
18
|
Low dopamine d(2) receptor binding in subregions of the thalamus in schizophrenia.
|
Am J Psychiatry
|
2004
|
0.91
|
|
19
|
Age-related decline of serotonin transporters in living human brain of healthy males.
|
Life Sci
|
2002
|
0.90
|
|
20
|
Age and disease related changes in the translocator protein (TSPO) system in the human brain: positron emission tomography measurements with [11C]vinpocetine.
|
Neuroimage
|
2011
|
0.90
|
|
21
|
Quantitative analysis of [11C]AZ10419369 binding to 5-HT1B receptors in human brain.
|
J Cereb Blood Flow Metab
|
2010
|
0.89
|
|
22
|
Reduced serotonin transporter binding in the insular cortex in patients with obsessive-compulsive disorder: a [11C]DASB PET study.
|
Neuroimage
|
2009
|
0.88
|
|
23
|
Effects of repetitive transcranial magnetic stimulation on [11C]raclopride binding and cognitive function in patients with depression.
|
J Affect Disord
|
2006
|
0.87
|
|
24
|
Positron emission tomography measurement of dopamine D₂ receptor occupancy in the pituitary and cerebral cortex: relation to antipsychotic-induced hyperprolactinemia.
|
J Clin Psychiatry
|
2010
|
0.87
|
|
25
|
Decreased 5-HT1A receptor binding in amygdala of schizophrenia.
|
Biol Psychiatry
|
2004
|
0.86
|
|
26
|
In vivo imaging of the 18-kDa translocator protein (TSPO) with [18F]FEDAA1106 and PET does not show increased binding in Alzheimer's disease patients.
|
Eur J Nucl Med Mol Imaging
|
2013
|
0.85
|
|
27
|
Decreased binding of [11C]NNC112 and [11C]SCH23390 in patients with chronic schizophrenia.
|
Life Sci
|
2010
|
0.84
|
|
28
|
AZD5213: a novel histamine H3 receptor antagonist permitting high daytime and low nocturnal H3 receptor occupancy, a PET study in human subjects.
|
Int J Neuropsychopharmacol
|
2012
|
0.83
|
|
29
|
Positron emission tomography imaging of the 18-kDa translocator protein (TSPO) with [18F]FEMPA in Alzheimer's disease patients and control subjects.
|
Eur J Nucl Med Mol Imaging
|
2014
|
0.82
|
|
30
|
GABAA/Benzodiazepine receptor binding in patients with schizophrenia using [11C]Ro15-4513, a radioligand with relatively high affinity for alpha5 subunit.
|
Schizophr Res
|
2007
|
0.82
|
|
31
|
Quantitative analysis of dopamine synthesis in human brain using positron emission tomography with L-[beta-11C]DOPA.
|
Nucl Med Commun
|
2006
|
0.81
|
|
32
|
Chronic repetitive transcranial magnetic stimulation failed to change dopamine synthesis rate: preliminary L-[β-11C]DOPA positron emission tomography study in patients with depression.
|
Psychiatry Clin Neurosci
|
2010
|
0.81
|
|
33
|
In vitro autoradiography and in vivo evaluation in cynomolgus monkey of [18F]FE-PE2I, a new dopamine transporter PET radioligand.
|
Synapse
|
2009
|
0.81
|
|
34
|
Norepinephrine transporter occupancy in the human brain after oral administration of quetiapine XR.
|
Int J Neuropsychopharmacol
|
2013
|
0.81
|
|
35
|
Changes in central 5-HT(1A) receptor binding in mesial temporal epilepsy measured by positron emission tomography with [(11)C]WAY100635.
|
Epilepsy Res
|
2006
|
0.80
|
|
36
|
Clozapine can induce high dopamine D(2) receptor occupancy in vivo.
|
Psychopharmacology (Berl)
|
2001
|
0.80
|
|
37
|
Increase in thalamic binding of [(11)C]PE2I in patients with schizophrenia: a positron emission tomography study of dopamine transporter.
|
J Psychiatr Res
|
2009
|
0.80
|
|
38
|
Quantitative analysis of dopamine transporters in human brain using [11C]PE2I and positron emission tomography: evaluation of reference tissue models.
|
Ann Nucl Med
|
2010
|
0.80
|
|
39
|
Role of ventral striatal dopamine D1 receptor in cigarette craving.
|
Biol Psychiatry
|
2006
|
0.79
|
|
40
|
Kinetic analysis and quantification of the dopamine transporter in the nonhuman primate brain with 11C-PE2I and 18F-FE-PE2I.
|
J Nucl Med
|
2011
|
0.79
|
|
41
|
Effect of electroconvulsive therapy on 5-HT1A receptor binding in patients with depression: a PET study with [11C]WAY 100635.
|
Int J Neuropsychopharmacol
|
2010
|
0.79
|
|
42
|
Electroconvulsive therapy decreases dopamine D₂receptor binding in the anterior cingulate in patients with depression: a controlled study using positron emission tomography with radioligand [¹¹C]FLB 457.
|
J Clin Psychiatry
|
2009
|
0.79
|
|
43
|
Abnormal effective connectivity of dopamine D2 receptor binding in schizophrenia.
|
Psychiatry Res
|
2005
|
0.78
|
|
44
|
In vivo drug action of tandospirone at 5-HT1A receptor examined using positron emission tomography and neuroendocrine response.
|
Psychopharmacology (Berl)
|
2002
|
0.77
|
|
45
|
Molecular Imaging of PDE10A Knockout Mice with a Novel PET Radiotracer: [(11)C]T-773.
|
Mol Imaging Biol
|
2015
|
0.77
|
|
46
|
Quantitative analyses of [¹¹C]Ro15-4513 binding to subunits of GABAA/benzodiazepine receptor in the living human brain.
|
Nucl Med Commun
|
2009
|
0.76
|
|
47
|
Measurement of glycine binding site of N-methyl-D-asparate receptors in living human brain using 4-acetoxy derivative of L-703,717, 4-acetoxy-7-chloro-3-[3-(4-[11c] methoxybenzyl) phenyl]-2(1H)-quinolone (AcL703) with positron emission tomography.
|
Synapse
|
2007
|
0.76
|
|
48
|
Extrastriatal dopamine D(2) receptor occupancy in olanzapine-treated patients with schizophrenia.
|
Eur Arch Psychiatry Clin Neurosci
|
2009
|
0.76
|
|
49
|
Quantitative analysis for estimating binding potential of the brain serotonin transporter with [11 C]McN5652.
|
J Cereb Blood Flow Metab
|
2002
|
0.76
|
|
50
|
Synthesis and evaluation of 2-chloro N-[(S)-{(S)-1-[11 C]methylpiperidin-2-yl} (phenyl)methyl]3-trifluoromethyl-benzamide ([11 C]N-methyl-SSR504734) as a PET radioligand for glycine transporter 1.
|
EJNMMI Res
|
2012
|
0.75
|
|
51
|
The necessary parameters for estimating the time-course of receptor occupancy.
|
Int J Neuropsychopharmacol
|
2005
|
0.75
|
|
52
|
Simplified quantification and whole-body distribution of [18F]FE-PE2I in nonhuman primates: prediction for human studies.
|
Nucl Med Biol
|
2011
|
0.75
|
|
53
|
[PET (positron emission tomography) research on schizophrenia].
|
Nihon Yakurigaku Zasshi
|
2006
|
0.75
|
|
54
|
The search of targets for novel antipsychotic drugs.
|
Curr Pharm Des
|
2010
|
0.75
|
|
55
|
Dopamine D2 receptor occupancy by perospirone: a positron emission tomography study in patients with schizophrenia and healthy subjects.
|
Psychopharmacology (Berl)
|
2010
|
0.75
|
|
56
|
Graphic plot analysis for estimating binding potential of translocator protein (TSPO) in positron emission tomography studies with [¹⁸F]FEDAA1106.
|
Neuroimage
|
2012
|
0.75
|
|
57
|
No inhibitory effect on P-glycoprotein function at blood-brain barrier by clinical dose of clarithromycin: a human PET study with [¹¹C]verapamil.
|
Ann Nucl Med
|
2010
|
0.75
|
|
58
|
Development of a series of novel carbon-11 labeled PDE10A inhibitors.
|
J Labelled Comp Radiopharm
|
2015
|
0.75
|
|
59
|
Effects of image reconstruction algorithm on neurotransmission PET studies in humans: comparison between filtered backprojection and ordered subsets expectation maximization.
|
Ann Nucl Med
|
2006
|
0.75
|